Sort
4,870 grants matching “glp 1”
SGLT2 Inhibition and Stimulation of Endogenous Glucose Production
$513,780Ralph A Defronzo · University Of Texas Hlth Science Center · R01 · FY2020 · DK
SGLT2 Inhibition and Stimulation of Endogenous Glucose Production
$513,574Ralph A Defronzo · University Of Texas Hlth Science Center · R01 · FY2017 · DK
Evaluating Mechanisms and Therapeutic Potential of (GLP-1R) Agonists for Glaucoma Treatment
$513,342Qi Nannan Cui · University Of Pennsylvania · R01 · FY2023 · EY
Functional Brain Imaging and Appetite-Related Hormones Pre and Post Obesity Surge
$512,706Allan Geliebter · St. Luke'S-Roosevelt Inst For Hlth Scis · R01 · FY2013 · DK
ApoE4-targeted therapeutics that normalize SirT1
$512,424Varghese John · University Of California Los Angeles · R01 · FY2015 · AG
GLP-1 to Enhance Islet Transplantation
$512,270Vanderbilt University · R33 · FY2005 · DK
Obesity Genes, Energy Regulation in Response to Weight-Loss Diets
$511,112Lu Qi · Harvard School Of Public Health · R01 · FY2012 · DK
In Vivo - In Vitro: Repurposing Itraconazole for toplical treatment of Basal Cell
$510,953Weill Medical Coll Of Cornell Univ · N01 · FY2012 · CA
Metabolism of islets of langerhans and hormone release
$510,750Franz M Matschinsky · University Of Pennsylvania · R01 · FY2007 · DK
The effect of endogenous GLP-1 secretion on islet function in vivo
$510,636Adrian Vella · Mayo Clinic Rochester · R01 · FY2021 · DK
The effect of endogenous GLP-1 secretion on islet function in vivo
$510,636Adrian Vella · Mayo Clinic Rochester · R01 · FY2023 · DK
The effect of endogenous GLP-1 secretion on islet function in vivo
$510,636Adrian Vella · Mayo Clinic Rochester · R01 · FY2022 · DK
The Chesapeake-Ohio Pharmacokinetics Core for The ETCTN
$510,158Jan Hendrik Beumer · Johns Hopkins University · U24 · FY2025 · CA
Immune Responses to CMV DNA Vaccination
$510,068Vical, Inc. · R01 · FY2004 · AI
A Shear Force Transfer Coupling for Soft Tissue Repair
$510,008David B Melvin · Cardioenergetics, Inc. · R44 · FY2006 · EB
CCL1 gene therapy to inhibit bacterial translocation in acute radiation syndromes
$509,429Fujio Suzuki · University Of Texas Med Br Galveston · U01 · FY2016 · AI
CCL1 gene therapy to inhibit bacterial translocation in acute radiation syndromes
$509,429Fujio Suzuki · University Of Texas Med Br Galveston · U01 · FY2015 · AI
CCL1 gene therapy to inhibit bacterial translocation in acute radiation syndromes
$509,429Fujio Suzuki · University Of Texas Med Br Galveston · U01 · FY2017 · AI
The Chesapeake-Ohio Pharmacokinetics Core for The ETCTN
$509,249Michelle A Rudek · Johns Hopkins University · U24 · FY2022 · CA
Preventing invasive prostate cancer
$508,994Raymond C Bergan · University Of Nebraska Medical Center · R01 · FY2024 · CA
CCL1 gene therapy to inhibit bacterial translocation in acute radiation syndromes
$508,934Fujio Suzuki · University Of Texas Med Br Galveston · U01 · FY2014 · AI
Evaluating Mechanisms and Therapeutic Potential of (GLP-1R) Agonists for Glaucoma Treatment
$508,731Qi Nannan Cui · University Of Pennsylvania · R01 · FY2024 · EY
Mechanism and therapeutic targeting of castration resistance in SPOP-mutated prostate cancer
$507,395Zhenkun Lou · Mayo Clinic Rochester · R01 · FY2024 · CA
Co-registration of Cell Organization, Phenotype and Function in the Human Pancreas During Type 1 Diabetes
$506,783Mark A Atkinson · University Of Florida · R01 · FY2022 · DK
Co-registration of Cell Organization, Phenotype and Function in the Human Pancreas During Type 1 Diabetes
$506,783Mark A Atkinson · University Of Florida · R01 · FY2023 · DK